Space and astronomy news
This artist’s impression shows the record-breaking quasar J059-4351, the bright core of a distant galaxy that is powered by a supermassive black hole. Credit: ESO/M. Kornmesser
As a general rule, astronomers gauge the growth rate of SMBHs based on the luminosity of their galaxy’s core region – the brighter the quasar, the faster the black hole is accreting matter. In this case, the SMBH at the core of J0529-4351 is growing by the equivalent of one Solar mass a day, making it the fastest-growing black hole yet observed.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
NYPD officer struck in head with object during NYC 'unlawful protest'NYPD Deputy Commissioner Kaz Daughtry shared the photos showing the officer with a staple in his head and the object allegedly used to strike him at a protest march from 39th St. to Columbus Circle.
Les mer »
The Ever-Evolving Dining Scene of Los AngelesExploring the diverse and constantly changing dining scene in Los Angeles
Les mer »
Largest-ever COVID vaccine study links shot to small increase in heart and brain conditionsA new study published in the journal Vaccine found that the COVID vaccine was linked to a slight increase in neurological, blood and heart-related medical conditions. Experts weighed in.
Les mer »
The Fisker Ocean Is The Worst Car MKBHD Has Ever ReviewedMKBHD (Marques Brownlee) says the Fisker Ocean is the worst car he has ever reviewed. Why? Because most of its functions don't ever work. Or sometimes do and sometimes don't.
Les mer »
Why Is the US Producing More Oil and Natural Gas Than Ever Under Biden?US crude oil production reached an all-time production high in 2023 -- the hottest year on record.
Les mer »
First-Ever CRISPR-Based Therapy Approved for Sickle Cell DiseaseU.S. patients with sickle cell disease now have a novel treatment option: the first-ever CRISPR-based therapy.for use in patients age 12 years and older. In addition to offering hope of relief for people with severe forms of the painful blood disorder, the treatment, called Casgevy, is the world’s first to genetically tweak cells using theAnother gene therapy for sickle cell disease, called Lyfgenia and developed by biotech company bluebird bio, based in Somerville, Mass., was also approved December 8. Getting a green light for the first CRISPR-based medicine is exciting, says David Altshuler, chief scientific officer at Boston-based Vertex Pharmaceuticals, which developed the drug in a joint venture with CRISPR Therapeutics, a company in Cambridge, Mass. But the fact that the drug fills an unmet need for underserved patients is “more compelling to me, personally, than the fact that it’s CRISPR.” , most of them Black or Latino, have sickle cell disease. It is caused by a genetic defect in hemoglobin, the oxygen-carrying protein in red blood cells
Les mer »